Exencial Wealth Advisors, LLC Novartis Ag Transaction History
Exencial Wealth Advisors, LLC
- $2.63 Billion
- Q1 2025
A detailed history of Exencial Wealth Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Exencial Wealth Advisors, LLC holds 118,019 shares of NVS stock, worth $13.7 Million. This represents 0.5% of its overall portfolio holdings.
Number of Shares
118,019
Previous 126,147
6.44%
Holding current value
$13.7 Million
Previous $12.3 Million
7.18%
% of portfolio
0.5%
Previous 0.46%
Shares
31 transactions
Others Institutions Holding NVS
# of Institutions
1,524Shares Held
142MCall Options Held
1.63MPut Options Held
1.82M-
Dodge & Cox San Francisco, CA11.8MShares$1.37 Billion0.81% of portfolio
-
Primecap Management CO Pasadena, CA10.4MShares$1.2 Billion0.98% of portfolio
-
Dimensional Fund Advisors LP Austin, TX8.61MShares$996 Million0.25% of portfolio
-
Morgan Stanley New York, NY7.06MShares$817 Million0.06% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa6.76MShares$783 Million0.33% of portfolio
About NOVARTIS AG
- Ticker NVS
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,151,000,064
- Market Cap $249B
- Description
- Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...